Publications in collaboration with researchers from Hospital Universitario de Salamanca (78)

2024

  1. Non-Mammalian Models for Understanding Neurological Defects in RASopathies

    Biomedicines, Vol. 12, Núm. 4

  2. PTEN hamartoma tumor syndrome: Clinical and genetic characterization in pediatric patients

    Child's Nervous System

2023

  1. Clinical description, molecular delineation and genotype-phenotype correlation in 340 patients with KBG syndrome: Addition of 67 new patients

    Journal of Medical Genetics, Vol. 60, Núm. 7, pp. 644-654

  2. Interleukin 5 Receptor Subunit Alpha Expression as a Potential Biomarker in Patients with Nasal Polyposis

    Biomedicines, Vol. 11, Núm. 7

  3. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  4. RNY3 modulates cell proliferation and IL13 mRNA levels in a T lymphocyte model: a possible new epigenetic mechanism of IL-13 regulation

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 1, pp. 59-69

  5. Transcriptomics reveals new regulatory mechanisms involved in benralizumab response

    Allergy: European Journal of Allergy and Clinical Immunology

2022

  1. Case Report: Pharmacogenetics Applied to Precision Psychiatry Could Explain the Outcome of a Patient With a New CYP2D6 Genotype

    Frontiers in Psychiatry, Vol. 12

  2. Identification of Germinal Neurofibromin Hotspots

    Biomedicines, Vol. 10, Núm. 8

  3. Polymorphisms in Human IL4, IL10, and TNF Genes Are Associated with an Increased Risk of Developing NSAID-Exacerbated Respiratory Disease

    Genes, Vol. 13, Núm. 4

  4. Ten Years of Experience Support Pharmacogenetic Testing to Guide Individualized Drug Therapy

    Pharmaceutics, Vol. 14, Núm. 1

2021

  1. Economic impact of the application of a precision medicine model (5SPM) on psychotic patients

    Pharmacogenomics and Personalized Medicine, Vol. 14, pp. 1015-1025

  2. Genetics and Epigenetics of Nasal Polyposis: A Systematic Review

    Journal of investigational allergology & clinical immunology, Vol. 31, Núm. 3, pp. 196-211

  3. Increased TPSAB1 Copy Number in a Family With Elevated Basal Serum Levels of Tryptase

    Frontiers in Medicine, Vol. 8

  4. Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins

    Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1

  5. Juvenile myelomonocytic leukemia in CBL syndrome associated with germline splice-site mutations: Two case reports and a literature review

    Clinical Case Reports, Vol. 9, Núm. 5

  6. Review: Influence of the cyp450 genetic variation on the treatment of psychotic disorders

    Journal of Clinical Medicine, Vol. 10, Núm. 18

2020

  1. Application of a pharmacogenetics-based precision medicine model (5SPM) to psychotic patients that presented poor response to neuroleptic therapy

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-16

  2. Atopy can be an interfering factor in genetic association studies of ß-lactam allergy

    Journal of Investigational Allergology and Clinical Immunology

  3. Genetics and epigenetics of atopic dermatitis: An updated systematic review

    Genes, Vol. 11, Núm. 4